RARA and acute promyelocytic leukemia: To extend our knowledge of subtle genetic alterations involved in APL that might cooperate with PML/RARA in the leukemogenic process, we have performed whole-exome sequencing (WES) of diagnosis-completed remission matched samples on a selected discovery cohort of de novo APL patients and targeted resequenced novel candidate genes in an extended cohort.